Enteral nutrition and drug administration, interactions, and complications

Nutrition in Clinical Practice

Volumn 20, Issue 6, 2005, Pages 618-624

  Magnuson, Barbara L ^a,b   Clifford, Timothy M ^a,b   Hoskins, Lora A ^b   Bernard, Andrew C ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALUMINUM; AMPHOTERICIN B; AMPICILLIN; ANTACID AGENT; ANTIINFECTIVE AGENT; ASCORBIC ACID; BICARBONATE; BISMUTH; CALCIUM; CALCIUM ACETATE; CHELATING AGENT; CIPROFLOXACIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; IRON; KETOCONAZOLE; LORATADINE; MAGNESIUM; PHENYTOIN; PHOSPHORUS; POTASSIUM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RISEDRONIC ACID; SODIUM; STEROID; SUCRALFATE; TETRACYCLINE; UNINDEXED DRUG;

ABDOMINAL DISTENSION; COST CONTROL; DEVICE; DIARRHEA; DIET THERAPY; DRUG ABSORPTION; DRUG ADMINISTRATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENTERIC FEEDING; FEEDING APPARATUS; FOOD DRUG INTERACTION; HUMAN; LIQUID; NUTRITIONAL SUPPORT; OUTCOMES RESEARCH; PATIENT CARE; REVIEW; STOMACH PROTECTION; STOMACH SECRETION;

EID: 29044436437     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0115426505020006618     Document Type: Review

References (37)

1. McWhirter JP, Pennington CR. Incidence and recognition of malnutrition in hospital. BMJ. 1994;308:945-948.
2. Braunschweig CL, Levy P, Sheean PM, Wang X. Enteral compared with parenteral nutrition: a meta-analysis. Am J Clin Nutr. 2001;74:534-542.
3. Marik PE, Zaloga GP. Early enteral nutrition in acutely ill patients: a systemic review. Crit Care Med. 2001;29:2264-2270.
4. Gianotti L, Alexander JW, Nelson JL, Fukushima R, Pyles T, Chalk CL. Role of early enteral feeding and acute starvation on postburn bacterial translocation and host defense: prospective, randomized trials. Crit Care Med. 1994;22:265-272.
5. Brown RO, Dickerson RN. Drug-nutrient interactions. Am J Manage Care. 1999;5:345-352.
6. Bernard AC, Magnuson BL, Tsuei B, Swintosky ME, Barnes S, Kearney PA. Defining and assessing tolerance in enteral nutrition. Nutr Clin Pract. 2004;19:481-486.
7. McCarthy MS, Fabling JC, Bell DE. Drug-nutrient interactions. In: Shikora SA, Martindale RG, Schwaitzberg SD, eds. Nutritional Considerations in the Intensive Care Unit. Dubuque, IA: Kendall/Hunt Publishing Company; 2002:153-171.
8. Heyland DK, Drover JW, MacDonald S, Novak F, Lam M. Effect of postpyloric feeding on gastroesophageal regurgitation and pulmonary microaspiration: results of a randomized controlled trial. Crit Care Med. 2001;29:1495-1501.
9. Heyland DK, Dhaliwal R, Day A, Jain M, Drover J. Validation of the Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients: results of a prospective observational study. Crit Care Med. 2004;32:2260-2266.
10. Davies AR, Froomes PR, French CJ, et al. Randomized comparison of nasojejunal and nasogastric feeding in critically ill patients. Crit Care Med. 2002;30:586-590.
11. Janssens J. Improvement of gastric emptying in diabetic gastroparesis by erythromycin: preliminary studies. N Engl J Med. 1990;322:1028-1031.
12. Cohn SM, Sawyer MD, Burns GA, Tolomeo C, Milner KA. Enteric absorption of ciprofloxacin during tube feeding in the critically ill. J Antimicrob Chemother. 1996;38:871-876.
13. Healy DP, Brodeck MC, Clendening CE. Ciprofloxacin absorption is impaired in patients given enteral feeding and via gastrostomy and jejunostomy tubes. Antimicrob Agents Chemother. 1996;40:6-10.
14. Marvel ME, Bertino J. Comparative effects of an elemental and a complex enteral feeding formulation on the absorption of phenytoin suspension. JPEN J Parenter Enteral Nutr. 1991;15:316-318.
15. Pugh C. Phenytoin and enteral feedings: a clinically significant interaction. Hosp Pharm. 1989;24:562-569.
16. Saklad JJ, Graves RH, Sharp WP. Interaction of oral phenytoin with enteral feedings. JPEN J Parenter Enteral Nutr. 1986;10: 322-323.
17. Sneed RC, Morgan WT. Interference of oral phenytoin absorption by enteral tube feedings. Arch Phys Med Rehabil. 1988;69:682-684.
18. Bauer LA. Interference of oral phenytoin absorption by continuous nasogastric feedings. Neurology. 1982;32:570-572.
19. Gilbert S, Hatten J, Magnuson B. How to minimize interaction between phenytoin and enteral feedings: two approaches. Nutr Clin Pract. 1996;11:28-31.
20. Yeung CS, Ensom MH. Phenytoin and enteral feedings: does the evidence support an interaction. Ann Pharmacother. 2000;34:896-905.
21. Bass J, Miles MV, Tennison MB, Holcombe BJ, Thorn MD. Effects of enteral tube feeding on the absorption and pharmacokinetic profile of carbamazepine suspension. Epilepsia. 1989;30:364-369.
22. Martin JE, Lutomski DM. Warfarin resistance and enteral feedings. JPEN J Parenter Enteral Nutr. 1989;13:206-208.
23. Mitchell JF, Leady MA. Oral Dosage Forms That Should Not Be Crushed: July 2004 Chart: Hospital Pharmacy. St. Louis, MO: Wolters Kluwer Health, Inc.; 2004.
24. Acifex package insert, Eisai Inc. Rev-11 Ver-1, August 2003.
25. Zegerid package insert, Santarus, Inc. San Diego, CA. August 2004.
26. Phillips JO, Metzler MH, Palmieri MT, Huckfeldt RE, Dahl NG. A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage. Crit Care Med. 1996;24:1793-1800.
27. Ley LM, Stahlheber-Dilg B, Sander P, Huber R, Mascher H, Lucker PW. Unavailability of a crushed pantoprazole tablet after buffering with sodium hydrogencarbonate or magaldrate relative to the intact enteric coated pantoprazole tablet. Clin Pharmacol. 2001;23:41-45.
28. DiGiacinto JL, Olsen KM, Bergman KL, Hoie EB. Stability of suspension formulations of lansoprazole and omeprazole stored in amber-colored plastic oral syringes. Ann Pharmacother. 2000;34:600-605.
29. Dentinger PJ, Swenson CF, Anaizi NH. Stability of pantoprazole in an extemporaneously compounded oral liquid. Am J Health Syst Pharm. 2002;59:953-956.
30. Green AE, Banks S, Jay M, Hatton J. Stability of nimodipine solution in oral syringes. Am J Health Syst Pharm. 2004;61:1493-1496.
31. Phillips J, Beam S, Brinker A, et al. Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm. 2001;58:1835-1841.
32. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-1367.
33. Roediger WE. Famine, fiber, fatty acids, and failed colonic absorption: does fiber fermentation ameliorate diarrhea? JPEN J Parenter Enteral Nutr. 1994;18:4-8.
34. Williams MS, Harper RA, Magnuson BL, Loan TD, Kearney PA. Diarrhea management in enterally fed patients. Nutr Clin Pract. 1998;13:225-229.
35. Elmer GW, McFarland LV. Biotherapeutic agents in the treatment of infectious diarrhea. Gastroenterol Clin North Am. 2001;30:837-854.
36. Dickerson RN, Melnik G. Osmolality of oral solutions and suspensions. Am J Hosp Pharm. 1988;45:832-834.
37. Laing RB, Makenzie AR, Shaw H, Gould IM, Dogulas JG. The effect of the intravenous to oral switch guidelines on the use of parenteral administration in medical wards. J Antimicrob Chemother. 1998;42:107-111.